Lymphomatoid granulomatosis differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 70: Line 70:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab 3
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab 3
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |X-ray
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |X-ray
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 2
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |CT scan
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 3
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 3
|-
|-
Line 84: Line 84:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |eosinophilia
| style="background: #F5F5F5; padding: 5px;" |Eosinophilia
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 98: Line 98:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Granulomatous disease of lungs in which almost all granulomas are centered in bronchi or bronchioles causing their destruction
* A histologic pattern of disease, not a specific diagnosis
* Usually adults, often with asthma history and limited to lungs, may be asymptomatic
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Churg-Strauss syndrome
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Churg-Strauss syndrome
Line 111: Line 114:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Greater than 50% have positive ANCA, often antimyeloperoxidase
* Eosinophilia
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |pulmonary infiltrates in at least half of the patients in the second phase of the disease and a greater percentage in the third phase of the disease. Typically, these are transient patchy alveolar infiltrates, usually without preferential, lobar, or segmental distribution. In some instances, a diffuse interstitial infiltrative pattern may be apparent.
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Subpleural airspace consolidation is an additional feature in about half of cases, whereas more widespread consolidation is discerned occasionally.
* Enlarged hilar or mediastinal lymph nodes also are apparent on pulmonary thin-section CT scan
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |

Revision as of 21:11, 3 December 2018

Lymphomatoid granulomatosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphomatoid granulomatosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphomatoid granulomatosis differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphomatoid granulomatosis differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphomatoid granulomatosis differential diagnosis

CDC on Lymphomatoid granulomatosis differential diagnosis

Lymphomatoid granulomatosis differential diagnosis in the news

Blogs on Lymphomatoid granulomatosis differential diagnosis

Directions to Hospitals Treating Lymphomatoid granulomatosis

Risk calculators and risk factors for Lymphomatoid granulomatosis differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Lymphamtoid granulomatosis must be differentiated from Bronchocentric granulomatosis and Churg-Strauss, Necrotizing sarcoid granulomatosis, Wegeners granulomatosis, Hodgkins disease, Non-hodgkin lymphoma, and Nasal angiocentric lymphoma

Differentiating Lymphamatoid granulomatosis from other Diseases

As Lymphamatoid granulomatosis manifests in a variety of clinical forms, differentiation must be established in accordance with the particular subtypes pulmonary being the most common. The sub types are the following:

  • Pulmonary
  • CNS
  • Dermatologic

Pulmonary Lymphamatoid granulomatosis must be differentiated from other diseases that cause:

  • Cough(non-productive, rarely hemoptysis can occur)
  • Dyspnea
  • Chest tightness

Other Symptoms that are asscociated with the pulmonary symptoms are:

  • Malaise
  • Weight loss
  • Fatigue

From the symptoms listed above; Lymphamatoid granulomatosis is usually differtiated from the following diseases Bronchocentric granulomatosis and Churg-Strauss, Necrotizing sarcoid granulomatosis, Wegeners granulomatosis, Hodgkins disease, Non-hodgkin lymphoma, and Nasal angiocentric lymphoma.

In contrast, CNS lymphamatoid granulomatosis must be differentiated from other diseases that cause:

  • Mental status changes
  • Headaches
  • Seizures
  • Hemiparesis
  • Ataxia

The differentials are the following CVA and Brain tumors or CNS lymphoma.

Finally Dermatologic Lymphamatoid granulomatosis must also be differtiated from other diseases that cause:

  • Erythematous rash
  • Macules
  • Papules
  • Plaques
  • Subcutaneous nodules
  • Larger ulcerated nodules

The differentials are the following Dermatomyositis, and Psoriasis

Differentiating Lymphamatoid Granulomatosis

On the basis of Cough, Dyspnea, and Chest tightness, Lymphamatoid granulomatosis must be differentiated from Bronchocentric granulomatosis and Churg-Strauss, Necrotizing sarcoid granulomatosis, Wegeners granulomatosis, Hodgkins disease, Non-hodgkin lymphoma, and Nasal angiocentric lymphoma.

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging Histopathology
Cough Dyspnea Chest tightness Auscultation Lab findings Lab 2 Lab 3 X-ray CT scan Imaging 3
Bronchocentric granulomatosis + + + Wheezing

Rales

Rhonchi

Eosinophilia
  • Usually solitary lesions that appear on chest Xray as atelectasis or consolidation, not nodules
  • Large and medium bronchi infiltrated by neutrophils, eosinophils and necrotic debris surrounded by foreign body giant cells
  • Fragmented elastic tissue (with elastic stain)
  • Also bronchiolitis obliterans
  • No fibrinoid necrosis of vessels
  • Granulomatous disease of lungs in which almost all granulomas are centered in bronchi or bronchioles causing their destruction
  • A histologic pattern of disease, not a specific diagnosis
  • Usually adults, often with asthma history and limited to lungs, may be asymptomatic
Churg-Strauss syndrome + + + Wheezing

Rales

Rhonchi

  • Greater than 50% have positive ANCA, often antimyeloperoxidase
  • Eosinophilia
pulmonary infiltrates in at least half of the patients in the second phase of the disease and a greater percentage in the third phase of the disease. Typically, these are transient patchy alveolar infiltrates, usually without preferential, lobar, or segmental distribution. In some instances, a diffuse interstitial infiltrative pattern may be apparent.
  • Subpleural airspace consolidation is an additional feature in about half of cases, whereas more widespread consolidation is discerned occasionally.
  • Enlarged hilar or mediastinal lymph nodes also are apparent on pulmonary thin-section CT scan
Necrotizing sarcoid granulomatosis + + - Wheezing
Diseases Symptom 1 Symptom 2 Symptom 3 Auscultation Lab 1 Lab 2 Lab 3 Imaging 1 Imaging 2 Imaging 3 Histopathology Gold standard Additional findings
Wegeners granulomatosis
Hodgkin disease
Non-hodgkin lymphoma

References

Template:WH Template:WS